Despite the development of vaccines and fast testing methods, SARS-CoV-2 continues to mutate and pose threats to our community. According to a recent news release by Healthy Davis Together, the P.1 variant of the virus has been identified in Yolo County.
The Vertebrate Genomes Project (VGP) today (April 28) announced their flagship study including high-quality, near error-free, and near complete reference genome assemblies for 16 species representing six major lineages of vertebrates, including mammals, reptiles, monotremes, amphibians and fish.
The David L. Weaver Endowed Lecture Series in Biophysics and Computational Biology is dedicated to the memory of David L. Weaver, a prominent biophysics researcher and professor at Tufts University.
Thank you to Dr. Eva Nogales for an insightful presentation for the 2021 David L. Weaver Endowed Lecture. You can watch Dr. Nogales' full presentation here. Note that it is necessary to log into your Zoom account to view the recording.
Blue coloring in nature is difficult to find; however, there is consumer demand for natural food coloring. Research conducted by Denish et al. (2021) in Science Advances describes the discovery of a cyan blue anthocyanin-based colorant. Synthetic biology and computational protein design tools were leveraged to develop an enzymatic transformation of red cabbage anthocyanins into the desired anthocyanin. This newly discovered cyan blue colorant could replace FD&C Blue No. 1.
The NIH has allocated US$190 million over 6 years in support of the Somatic Cell Genome Editing (SCGE) Consortium, which now includes 72 principal investigators from 38 institutions that are pursuing 45 distinct but well-integrated projects. The Genome Center professor David Segal is part of three projects at UC Davis, along with Alice Tarantal, Dennis Hartigan-O'Connor, Kit Lam, and R. Holland Cheng. A paper describing this effort appears in the April 8, 2021 issue of Nature.
This year's speaker is Dr. Eva Nogales, Professor of Biochemistry, Biophysics, and Structural Biology at UC Berkley. Nogales' talk is titled "Complexity and modularity in large human transcriptional cofactors."
Together, several Genome Center faculty have catalogued regulatory genes in chickens, cattle, and pigs that could lead to improvements in breeding these important farm animals.
Fereydoun Hormozdiari was recently awarded an NSF CAREER award for "Computational methods to improve our understanding of the diversity of genomic structural variation." As part of this project, Hormozdiari's Lab will develop novel methods for efficient and accurate discovery and genotyping of any structural variant using ever-changing sequencing technologies. This will provide the necessary methods for studying a diverse set of structural variants (including hard to detect and complex structural variants) using these technologies.
The Academic Senate Committee on Public Service has recognized Richard Michelmore, director of the Genome Center and distinguished professor in the Department of Plant Sciences, for his outstanding contributions and commitment to public service with the 2020-21 Distinguished Scholarly Public Service Award.
In a year of great uncertainty, Michelmore demonstrated exceptional vision, leadership, and scholarly excellence by spearheading the development of methods for the universal testing of the SARS-Cov-2 viroid at the Genome Center on the UC Davis campus.
Siobhan Brady was recently profiled on The Scientist, where readers learn more about Brady's research background, beginning with her childhood interest in heavy metals and culminating in her current work on gene expression and regulation in tomato.
UC Davis Virologist Samuel L. Díaz-Muñoz, an assistant professor in the Department of Microbiology and Molecular Genetics, spoke with KCRA 3 in an interview late last year about the mRNA COVID-19 vaccines being hailed “as game-changers” by the medical community.
The community-based approach for keeping Davis residents as well as university staff and students healthy was recently highlighted by the New York Times. In contrast to other universities, which have focused on testing only students and employees, UC Davis had a larger vision: to keep the whole community healthy.
